Logo image of DIM.PA

SARTORIUS STEDIM BIOTECH (DIM.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:DIM - FR0013154002 - Common Stock

207.3 EUR
+4.3 (+2.12%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

5

DIM gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 19 industry peers in the Life Sciences Tools & Services industry. DIM has an average financial health and profitability rating. DIM is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year DIM was profitable.
In the past year DIM had a positive cash flow from operations.
In the past 5 years DIM has always been profitable.
In the past 5 years DIM always reported a positive cash flow from operatings.
DIM.PA Yearly Net Income VS EBIT VS OCF VS FCFDIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

The Return On Assets of DIM (3.35%) is worse than 63.16% of its industry peers.
The Return On Equity of DIM (6.54%) is comparable to the rest of the industry.
DIM has a Return On Invested Capital (5.94%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for DIM is in line with the industry average of 9.25%.
The last Return On Invested Capital (5.94%) for DIM is well below the 3 year average (10.41%), which needs to be investigated, but indicates that DIM had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.35%
ROE 6.54%
ROIC 5.94%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
DIM.PA Yearly ROA, ROE, ROICDIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With a Profit Margin value of 8.96%, DIM perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
DIM's Profit Margin has declined in the last couple of years.
DIM has a better Operating Margin (16.63%) than 63.16% of its industry peers.
In the last couple of years the Operating Margin of DIM has declined.
DIM has a Gross Margin of 45.64%. This is in the better half of the industry: DIM outperforms 68.42% of its industry peers.
In the last couple of years the Gross Margin of DIM has declined.
Industry RankSector Rank
OM 16.63%
PM (TTM) 8.96%
GM 45.64%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
DIM.PA Yearly Profit, Operating, Gross MarginsDIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DIM is creating some value.
Compared to 1 year ago, DIM has more shares outstanding
Compared to 5 years ago, DIM has more shares outstanding
DIM has a better debt/assets ratio than last year.
DIM.PA Yearly Shares OutstandingDIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DIM.PA Yearly Total Debt VS Total AssetsDIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 4.45 indicates that DIM is not in any danger for bankruptcy at the moment.
DIM has a better Altman-Z score (4.45) than 84.21% of its industry peers.
The Debt to FCF ratio of DIM is 6.84, which is on the high side as it means it would take DIM, 6.84 years of fcf income to pay off all of its debts.
DIM has a Debt to FCF ratio of 6.84. This is comparable to the rest of the industry: DIM outperforms 42.11% of its industry peers.
DIM has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.50, DIM is in line with its industry, outperforming 57.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.84
Altman-Z 4.45
ROIC/WACC0.67
WACC8.83%
DIM.PA Yearly LT Debt VS Equity VS FCFDIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

DIM has a Current Ratio of 1.05. This is a normal value and indicates that DIM is financially healthy and should not expect problems in meeting its short term obligations.
DIM has a Current ratio of 1.05. This is in the lower half of the industry: DIM underperforms 68.42% of its industry peers.
DIM has a Quick Ratio of 1.05. This is a bad value and indicates that DIM is not financially healthy enough and could expect problems in meeting its short term obligations.
DIM has a worse Quick ratio (0.50) than 78.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.5
DIM.PA Yearly Current Assets VS Current LiabilitesDIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.11% over the past year.
Measured over the past 5 years, DIM shows a small growth in Earnings Per Share. The EPS has been growing by 4.19% on average per year.
Looking at the last year, DIM shows a small growth in Revenue. The Revenue has grown by 7.72% in the last year.
DIM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.05% yearly.
EPS 1Y (TTM)35.11%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%23.68%
Revenue 1Y (TTM)7.72%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%7.67%

3.2 Future

The Earnings Per Share is expected to grow by 22.11% on average over the next years. This is a very strong growth
DIM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.12% yearly.
EPS Next Y28.28%
EPS Next 2Y23.34%
EPS Next 3Y22.86%
EPS Next 5Y22.11%
Revenue Next Year8.96%
Revenue Next 2Y9.07%
Revenue Next 3Y9.84%
Revenue Next 5Y10.12%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DIM.PA Yearly Revenue VS EstimatesDIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
DIM.PA Yearly EPS VS EstimatesDIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 48.10 indicates a quite expensive valuation of DIM.
Based on the Price/Earnings ratio, DIM is valued a bit more expensive than the industry average as 78.95% of the companies are valued more cheaply.
DIM is valuated expensively when we compare the Price/Earnings ratio to 26.31, which is the current average of the S&P500 Index.
DIM is valuated quite expensively with a Price/Forward Earnings ratio of 38.93.
DIM's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. DIM is more expensive than 78.95% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.56. DIM is around the same levels.
Industry RankSector Rank
PE 48.1
Fwd PE 38.93
DIM.PA Price Earnings VS Forward Price EarningsDIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DIM indicates a rather expensive valuation: DIM more expensive than 84.21% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DIM indicates a slightly more expensive valuation: DIM is more expensive than 63.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 53.88
EV/EBITDA 27.79
DIM.PA Per share dataDIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

DIM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as DIM's earnings are expected to grow with 22.86% in the coming years.
PEG (NY)1.7
PEG (5Y)11.47
EPS Next 2Y23.34%
EPS Next 3Y22.86%

More info and screens

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.34%, DIM is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.70, DIM has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, DIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.34%

5.2 History

The dividend of DIM has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
DIM.PA Yearly Dividends per shareDIM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

DIM pays out 25.41% of its income as dividend. This is a sustainable payout ratio.
The dividend of DIM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.41%
EPS Next 2Y23.34%
EPS Next 3Y22.86%
DIM.PA Yearly Income VS Free CF VS DividendDIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DIM.PA Dividend Payout.DIM.PA Dividend Payout, showing the Payout Ratio.DIM.PA Dividend Payout.PayoutRetained Earnings

More info and screens

SARTORIUS STEDIM BIOTECH

EPA:DIM (11/28/2025, 7:00:00 PM)

207.3

+4.3 (+2.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-16 2025-10-16/bmo
Earnings (Next)01-26 2026-01-26/amc
Inst Owners11.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.18B
Revenue(TTM)2.95B
Net Income(TTM)264.10M
Analysts81.11
Price Target238.84 (15.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.34%
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP25.41%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.99%
Min EPS beat(2)-2.24%
Max EPS beat(2)10.22%
EPS beat(4)3
Avg EPS beat(4)9.45%
Min EPS beat(4)-2.24%
Max EPS beat(4)22.18%
EPS beat(8)3
Avg EPS beat(8)-1.58%
EPS beat(12)3
Avg EPS beat(12)-11.08%
EPS beat(16)4
Avg EPS beat(16)-13.1%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-3.94%
Max Revenue beat(2)0.3%
Revenue beat(4)3
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-3.94%
Max Revenue beat(4)3.52%
Revenue beat(8)5
Avg Revenue beat(8)-0.23%
Revenue beat(12)5
Avg Revenue beat(12)-1.54%
Revenue beat(16)7
Avg Revenue beat(16)-0.72%
PT rev (1m)-0.23%
PT rev (3m)-0.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.76%
EPS NY rev (1m)0.52%
EPS NY rev (3m)0.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.06%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 48.1
Fwd PE 38.93
P/S 6.85
P/FCF 53.88
P/OCF 27.62
P/B 5
P/tB N/A
EV/EBITDA 27.79
EPS(TTM)4.31
EY2.08%
EPS(NY)5.32
Fwd EY2.57%
FCF(TTM)3.85
FCFY1.86%
OCF(TTM)7.51
OCFY3.62%
SpS30.27
BVpS41.47
TBVpS-4.02
PEG (NY)1.7
PEG (5Y)11.47
Graham Number63.42
Profitability
Industry RankSector Rank
ROA 3.35%
ROE 6.54%
ROCE 7.46%
ROIC 5.94%
ROICexc 6.26%
ROICexgc 21.64%
OM 16.63%
PM (TTM) 8.96%
GM 45.64%
FCFM 12.71%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexgc growth 3Y-36.77%
ROICexgc growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.84
Debt/EBITDA 2.5
Cap/Depr 113.12%
Cap/Sales 12.09%
Interest Coverage 3.09
Cash Conversion 90.78%
Profit Quality 141.8%
Current Ratio 1.05
Quick Ratio 0.5
Altman-Z 4.45
F-Score8
WACC8.83%
ROIC/WACC0.67
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)35.11%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%23.68%
EPS Next Y28.28%
EPS Next 2Y23.34%
EPS Next 3Y22.86%
EPS Next 5Y22.11%
Revenue 1Y (TTM)7.72%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%7.67%
Revenue Next Year8.96%
Revenue Next 2Y9.07%
Revenue Next 3Y9.84%
Revenue Next 5Y10.12%
EBIT growth 1Y25.54%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year92.67%
EBIT Next 3Y37.11%
EBIT Next 5Y27.7%
FCF growth 1Y219.27%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y15.97%
OCF growth 3Y5.11%
OCF growth 5Y21.32%

SARTORIUS STEDIM BIOTECH / DIM.PA FAQ

What is the fundamental rating for DIM stock?

ChartMill assigns a fundamental rating of 5 / 10 to DIM.PA.


What is the valuation status for DIM stock?

ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS STEDIM BIOTECH (DIM.PA). This can be considered as Overvalued.


What is the profitability of DIM stock?

SARTORIUS STEDIM BIOTECH (DIM.PA) has a profitability rating of 5 / 10.


How financially healthy is SARTORIUS STEDIM BIOTECH?

The financial health rating of SARTORIUS STEDIM BIOTECH (DIM.PA) is 4 / 10.


How sustainable is the dividend of SARTORIUS STEDIM BIOTECH (DIM.PA) stock?

The dividend rating of SARTORIUS STEDIM BIOTECH (DIM.PA) is 4 / 10 and the dividend payout ratio is 25.41%.